Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Experimental Neurology
|
January 9, 2018
Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease
Oluwaseun Fatoba, Eugen Kloster, Christiane Reick, et al.
Experimental Neurology
|
September 3, 2016
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
Christiane Reick, Gisa Ellrichmann, Teresa Tsai, et al.
Plos One
|
February 8, 2011
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease
Gisa Ellrichmann, Elisabeth Petrasch-Parwez, De-Hyung Lee, et al.
Journal of Neurology
|
November 1, 2018
Peripheral CD19<sup>+</sup> B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
Gisa Ellrichmann, Jan Bolz, Maren Peschke, et al.
Journal of Neuroinflammation
|
May 8, 2020
Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells
Thomas Grüter, Alina Blusch, Jeremias Motte, et al.
Therapeutic Advances in Neurological Disorders
|
August 11, 2021
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis
Maike F Dohrn, Gisa Ellrichmann, Rastislav Pjontek, et al.
Brain and Behavior
|
November 6, 2025
Epidemiology of Parkinson's Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data
Dirk Woitalla, Gisa Ellrichmann, Stefan Jun Groiss, et al.
Scientific Reports
|
July 12, 2017
Laquinimod treatment in the R6/2 mouse model
Gisa Ellrichmann, Alina Blusch, Oluwaseun Fatoba, et al.
Scientific Reports
|
March 16, 2019
Author Correction: Laquinimod treatment in the R6/2 mouse model
Gisa Ellrichmann, Alina Blusch, Oluwaseun Fatoba, et al.
Plos One
|
May 23, 2013
Diagnostic value of the impairment of olfaction in Parkinson's disease
Swaantje Casjens, Angelika Eckert, Dirk Woitalla, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Experimental Neurology
|
January 9, 2018
Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease
Oluwaseun Fatoba, Eugen Kloster, Christiane Reick, et al.
Experimental Neurology
|
September 3, 2016
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
Christiane Reick, Gisa Ellrichmann, Teresa Tsai, et al.
Plos One
|
February 8, 2011
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease
Gisa Ellrichmann, Elisabeth Petrasch-Parwez, De-Hyung Lee, et al.
Journal of Neurology
|
November 1, 2018
Peripheral CD19<sup>+</sup> B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
Gisa Ellrichmann, Jan Bolz, Maren Peschke, et al.
Journal of Neuroinflammation
|
May 8, 2020
Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells
Thomas Grüter, Alina Blusch, Jeremias Motte, et al.
Therapeutic Advances in Neurological Disorders
|
August 11, 2021
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis
Maike F Dohrn, Gisa Ellrichmann, Rastislav Pjontek, et al.
Brain and Behavior
|
November 6, 2025
Epidemiology of Parkinson's Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data
Dirk Woitalla, Gisa Ellrichmann, Stefan Jun Groiss, et al.
Scientific Reports
|
July 12, 2017
Laquinimod treatment in the R6/2 mouse model
Gisa Ellrichmann, Alina Blusch, Oluwaseun Fatoba, et al.
Scientific Reports
|
March 16, 2019
Author Correction: Laquinimod treatment in the R6/2 mouse model
Gisa Ellrichmann, Alina Blusch, Oluwaseun Fatoba, et al.
Plos One
|
May 23, 2013
Diagnostic value of the impairment of olfaction in Parkinson's disease
Swaantje Casjens, Angelika Eckert, Dirk Woitalla, et al.
Page
of 6